University of Queensland researchers have shown that endometriosis and irritable bowel syndrome (IBS) share genetic risk factors, explaining why patients with one condition may also have the other.

Professor Grant Montgomery and Dr Sally Mortlock at UQ’s Institute for Molecular Bioscience found a significant relationship between the risks for endometriosis and common gastrointestinal disorders such as IBS, peptic ulcer disease (PUD) and gastro-oesophageal reflux disease (GORD).

“This genetic finding supports the clinical observation of an increased incidence of gastrointestinal disorders in women with endometriosis,” Professor Montgomery said.

“We hope that this study will raise more awareness about the overlap of these conditions.”

Endometriosis is a severe condition affecting 1 in 7 women caused by tissue that resembles the uterus lining growing outside the uterus.

Women with endometriosis are twice as likely to have an IBS diagnosis compared to women without the disease and 1.4 times more likely to have a diagnosis of GORD.

“Sufferers can find it difficult to distinguish the source of their pain leading to confusion or misdiagnosis and years of delay in treatment during which time the endometriosis can progress to more severe disease,” Professor Montgomery said.

“Endometriosis should be considered as a possible cause if a woman presents to her GP with abdominal pain and gastrointestinal symptoms.

“As our knowledge of risk factors for endometriosis increases, we hope to move closer to understanding how the disease develops and improve treatments and diagnosis,” he said.

Professor Montgomery and Dr Mortlock worked with Dr Fei Yang from IMB and colleagues at UQ’s School of Public Health on the genetic studies.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Before you post, please prove you are sentient.

what is 4 in addition to 4?

Explore More

Determining precise timing of cellular growth to understand the origins of cancer

Cancers are diseases of abnormal cellular growth, and although many are treatable or even curable, their origins are not necessarily clear. Understanding the precise timing of cellular events — as

New treatment in development for irritable bowel syndrome with constipation

Patients suffering from irritable bowel syndrome with constipation (IBS-C) have long needed an upgrade in treatment. Rapid-release, cramp-inducing doses of chenodeoxycholic acid (CDC) have previously shown promise in treating constipation,

How gravity may cause irritable bowel syndrome

A new theory suggests irritable bowel syndrome (IBS), the most common gastrointestinal disorder, may be caused by gravity. Brennan Spiegel, MD, MSHS, director of Health Services Research at Cedars-Sinai and